Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Clark

Showing results (291-300 of 297) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 297 results.
Leukemia|February 4, 2016
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trialA Hochhaus, G Saglio, T P Hughes, et al.
Leukemia|November 20, 2009
Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA allelesB E Shaw, N P Mayor, N H Russell, et al.
Bone Marrow Transplantation|July 1, 1997
European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationA Devergie, J F Apperley, M Labopin, et al.
Leukemia|January 12, 2020
A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual diseaseG A Horne, J Stobo, C Kelly, et al.
Leukemia|March 19, 2015
The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European CountriesV S Hoffmann, M Baccarani, J Hasford, et al.
Leukemia|March 5, 2020
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemiaA Hochhaus, M Baccarani, R T Silver, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party databaseR Saccardi, T Kozak, C Bocelli-Tyndall, et al.
Pageof 30

Showing results (291-300 of 297) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 297 results.
Leukemia|February 4, 2016
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trialA Hochhaus, G Saglio, T P Hughes, et al.
Leukemia|November 20, 2009
Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA allelesB E Shaw, N P Mayor, N H Russell, et al.
Bone Marrow Transplantation|July 1, 1997
European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationA Devergie, J F Apperley, M Labopin, et al.
Leukemia|January 12, 2020
A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual diseaseG A Horne, J Stobo, C Kelly, et al.
Leukemia|March 19, 2015
The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European CountriesV S Hoffmann, M Baccarani, J Hasford, et al.
Leukemia|March 5, 2020
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemiaA Hochhaus, M Baccarani, R T Silver, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party databaseR Saccardi, T Kozak, C Bocelli-Tyndall, et al.
Pageof 30